Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| Bronchoscopy & lung nodule · Florida | Bronchoscopy & lung nodule · Texas | |
|---|---|---|
| Surgeons, 2024 | 120 | 98 |
| Medicare fee-for-service cases | 7,940 | 6,069 |
| Growth since 2019 (Medicare FFS) | +6.4%/yr | +1.9%/yr |
| Forecast cases (Medicare FFS) | 13,100 in 2030 | 9,990 in 2030 |
| Forecast growth | +8.7%/yr to 2030 | +8.7%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 3.6 | 2.9 |
| Medicare Advantage share | 60% | 59% |
| Out of hospital | 0% (+0 pts since 2019) | 0% (−0 pts since 2019) |
| Cases per surgeon | 66 | 62 |
| Top 10 surgeons' share | 29% | 29% |
| Surgeons growing | 23 | 17 |
| New since the base year | 39 | 30 |
| Likely to stop billing it | 24 by 2026 | 18 by 2026 |
| Forecast miss, 1 year (procedure) | 6% | 6% |
| Company payments per surgeon | $6,303 | $3,773 |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.